GSK company profile
Company profile
GSK has 66,841 employees and is headquartered in London, United Kingdom.
Shingles, RSV and HPV vaccines, HIV medicines, and inhalers for asthma and COPD are the products most people associate with the group. Its work covers vaccines, specialty medicines and general medicines, and it also develops oral small-molecule therapies for oncology and inflammatory diseases. Customers are in the United Kingdom, the United States and other markets abroad, and its collaborations include an mRNA vaccine project with CureVac and a tuberculosis alliance with AN2 Therapeutics.
In the fiscal year ended December 2025, revenue was GBP 32.7 billion, up 4.1% from the previous year, and net profit reached GBP 5.7 billion. The United States generated 51.6% of revenue, international markets 25.3%, Europe 21.0% and Britain 2.1%. The company employed 66,841 people and is headquartered in London, where it was founded in 1715 and changed its name from GlaxoSmithKline to GSK plc in May 2022. Its shares also trade on the New York Stock Exchange.
Company facts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United Kingdom
- Headquarters
- 79 New Oxford Street, WC1A 1DG, London
- Employees
- 66,841
- Chief executive
- Luke Miels
- Founded
- 1715
- Fiscal year
- January - December
- Listing
- GSK · LSE
- Indices
- FTSE 100
- Currency
- GBp
- ISIN
- GB00BN7SWP63
- Website
- gsk.com
GSK and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| GSKGSK | United Kingdom | $102.04B | 66,841 | 30.5% | 18.0 |
| SanofiSAN | France | $116.52B | 74,846 | 22.3% | 25.5 |
| BayerBAYN | Germany | $61.54B | 87,775 | 16.5% | — |
| Novo NordiskNOVO.B | Denmark | $184.87B | 68,794 | 50.8% | 11.2 |
| AstraZenecaAZN | United Kingdom | $287.12B | 96,100 | 25.8% | 26.6 |
| NovartisNOVN | Switzerland | $305.16B | 75,267 | 34.0% | 32.6 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
